...
• 2,225,137 experimental records
• 602 experimentally measured drug pairs
• Blind pair-level benchmark
• 20×10 cross-validation
• 99.5% validation coverage
Validation:
Correlation = 0.617327
MAE = 3.971799
Null model MAE = 4.656203
Sign accuracy = 64.69%
Permutation p = 0.000100
Top HSA hypotheses:
• Dactinomycin + Vinblastine sulfate (9.096)
• Cabazitaxel + Vinblastine sulfate (8.224)
• Mitoxantrone + Vinblastine sulfate (7.254)
• Cabazitaxel + Mitoxantrone (7.128)
• Dactinomycin + Daunorubicin HCl (6.965)
Generated laboratory validation protocols (8×8 dose matrix, HSA, Bliss, Loewe, ZIP).
Computational hypotheses only. Independent laboratory validation required.
Petoron | Ivan Alekseev